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Abstract:  Problem statement: The enzyme β-glucuronidase is being used as a reporter molecule in 
the area of genetic engineering, as a component of prodrug therapy in cancer treatment and in the 
scouring process of cotton fabrics. However, a detailed understanding of the factors responsible for the 
stability and the activity of this enzyme is still not available. Molecular Dynamics (MD) simulations 
provide an estimate of equilibrium and dynamic properties of enzyme systems that cannot be 
calculated analytically. With this perspective, molecular dynamics simulations of human β-
glucuronidase (GUS) have been carried out to determine the behavior of this enzyme in vacuum and 
solvent environments at a defined temperature. Approach: CHARMM force field along with distance 
dependent dielectric model was used to represent the solvent environment in the MD simulations.  The 
parameters employed in various stages of MD simulations had been selected based on repeated trials 
under various conditions as a method of choosing the optimum parameters for each stage.  Results: It 
was found that simulations in vacuum caused the backbone of GUS to have smaller fluctuations from 
their mean values compared with the fluctuation in implicit solvent simulations, due to the fact that 
vacuum environment did not provide for the electrostatic interactions affecting the backbone of GUS 
that may otherwise exist in a solvent environment. Conclusion: Inclusion of solvent effects in MD 
simulations is crucial in understanding structural flexibility and stability of β-glucuronidase. Implicit 
solvent method can provide a realistic inclusion of backbone flexibility and structural compactness of 
GUS, which will have profound influence on the stability and activity of the enzymes, with a marginal 
increase in computational time. 
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INTRODUCTION 
 
 Human β-glucuronidase belongs to family 2 
glycosyl hydrolases that cleave β-D-glucuronic acid 
residues from the non reducing termini of 
glycosaminoglycans. In humans, the lysosomal β-
glucuronidase degrades sulfated glycosaminoglycans. 
The X-ray structure of a human β-glucuronidase has 
been  determined,  which  shows it to be a tetramer 
(Jain et al., 1996), with each monomer 653 amino acid 
residues long and a size of 80 kDa. It was revealed that 
each monomer of the human GUS structure has three 
structural domains, namely the jelly roll barrel, 
immunoglobulin constant domain and a 
Triosephosphateisomerase (TIM) barrel, in addition to 
it having an overall fold similarity to the N-terminal 
region of E. coli β-galactosidase. The active site of 
human β-glucuronidase has been based on the 
experimentally determined active site in E. coli β-
galactosidase and corresponds to the amino acid 
residues Glu451, Glu540 and Tyr504. The nature of the 
active site residues have been discussed previously 
(Islam et al., 1999). 
 Although significant experimental work has been 
reported on human GUS enzymes, computational 
studies of human GUS have not emerged as yet. To 
carry out in silico studies on an enzyme, the tool of 
Molecular Dynamics has been widely used in the past 
to efficiently explore the stability and related biological 
activity of biomolecules. In the current work, Molecular 
Dynamics simulation has been applied to explore the 
structural changes in human β-glucuronidase in two 
different environments, i.e., vacuum and implicit 
solvent. Prior to commencing the first stage of MD 
simulation, short term simulation trials were carried out 
using a “standard dynamics cascade” method, whereby 
parameters for each stage were defined in the beginning 
and each simulation stage ran successively after the 
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other as one complete process. This method allowed for 
the selection of optimum parameters for long term 
simulation.  
 
MATERIALS AND METHODS 
 
 All simulations reported here were carried out 
using Discovery Studio© v2.1.0.8130, built on the 
SciTegic Enterprise Server platform (Accelrys Inc, 
2008). Snapshots were taken by using VMD software, 
version 1.8.6 (Humphrey et al., 1996). 
 
System Preparation:  In order to prepare a sample for 
MD simulation, a model system consisting of N 
particles is selected and Newton's equations of motion 
are solved for this system until the properties of the 
system reach a stable value, or more appropriately 
reach equilibration. Afterwards the actual measurement 
can be carried out, i.e., production phase. The crystal 
structure of Human GUS from PDB (PDB ID: BHGA) 
was prepared for simulation by selecting only one chain 
and removing the heteroatoms. Before applying the 
force field, missing atoms were added in case of 
incomplete side-chain or backbone, hydrogen atoms 
were added and connectivity and bond orders were 
corrected. The Chemistry at HARvard Macromolecular 
Mechanics (CHARMM) program was used for 
performing all the molecular dynamics simulations. It 
performs standard molecular dynamics in many 
different ensembles, long-range force calculations and 
employs various implicit and explicit solvation models.  
All structures were typed with CHARMM force field 
(Brooks et al., 1983) with the Momany-Rone partial 
charge estimation method (Momany and Rone, 1992). 
The total charge of each human GUS after applying this 
method was -6, whereas the pH was 7. The simulation 
environment depends on the solvent used for the 
enzyme and one can use explicit solvent, implicit 
solvent or no solvent, i.e. vacuum environment. 
Choosing explicit solvent increases the degrees of 
freedom in the system and therefore can incur a 
significant computational cost. An approach which can 
approximate the effects of solvation without explicitly 
representing solvent atoms is the implicit solvent model 
approach in which the polar and non polar effects of the 
solvent are accounted for in an averaged way. The 
implicit solvent method used in this study is the 
distance dependent dielectrics method, in which the 
dielectric constant, ε, is no longer a constant and 
increases linearly with the distance between two solute 
atoms, or, ε = ε0rij. When the distance rij is large, the 
effective dielectric constant is large and the electrostatic 
interaction between two non-solvent atoms decreases. 
This approach though is a rough estimation but gives 
relatively good results even for complex systems 
(Becker and Karplus, 2006). We also applied vacuum 
environment for the system, in order to have two sets of 
simulation results which can give insights into the 
differing behavior of the enzyme in two different 
environments. 
 
Minimization:  The starting structure had a very high 
RMS gradient (>4000 kcal molÅ−1). Thus, 2000 steps 
of steepest descent algorithm were used to rapidly 
improve a very poor conformation.  In this method, the 
gradient of the potential is calculated at each step. The 
aim of applying steepest descent is not to reach a local 
energy minimum, but to reach a considerably stable 
conformation. After obtaining considerable stability, 
10,000 steps of a second minimization algorithm, the 
conjugated gradients method was applied until the RMS 
gradient of the structure reached below 0.0001 kcal 
molÅ−1.  
 Since a direct evaluation of all the non-bonded 
interactions involving all atom pairs is highly complex, 
a suitable cut-off scheme is employed to reduce this 
cost-intensive task, without destroying the value of 
simulation of biomolecules. In this respect the spherical 
cut-off scheme yields reasonable approximations to the 
energy and force functions up to some threshold 
separation-distance value, as given by the non-bond list 
radius. In this method, a non-bonded list is created, 
which includes all pair interactions, i.e., van der Waals 
and electrostatic interactions. During energy 
minimization or MD simulation, the non-bonded list is 
updated according to a heuristic test, based on the 
defined non-bond list radius and non-bond higher cutoff 
distance parameter values, performed at each step of 
minimization or MD simulation. When applying the 
non-bonded cut-off scheme, the efficiency of the non-
bonded calculation is increased by including only atom 
pairs that are closer than the cutoff distance in a non-
bonded list. For the simulations in vacuum the regular 
columbic electrostatic interaction terms were applied, 
having a uniform dielectric constant of ε = 1. As for 
implicit solvent the dielectric constant was also chosen 
to be the same. The non-bond list radius of 14 Å is used 
for counting non-bonded interaction pairs. Beyond this 
cut-off distance, non-bonded interactions between atom 
pairs are ignored. The same distance criteria are used in 
subsequent simulations. 
 
Heating:  The structure was heated to the desired 
temperature as part of the preparation procedure. The 
target temperature for production step is 300 K 
therefore heating phase was applied at 300 K as well.  
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During the heating stage MD simulations were carried 
out for 6000 steps, with a step size of 0.001 ps.  The 
initial temperature for this heating process is 50 K and 
the final target temperature is 300 K and the velocities 
are adjusted in every 50 steps.  
 
Equilibration:  Prior to the production stage, the 
system was equilibrated by allowing it to evolve 
spontaneously for a period of time and integrating the 
equations of motion until the average temperature and 
structure remained stable and the total energy 
converged. This was facilitated by periodically 
reassigning velocities appropriate to the desired 
temperatures, which in this study was 300 K. As given 
in Table 1, the total number of steps to perform the 
dynamics simulation was 50000 with a step size of 
0.0005 ps. The Leapfrog Verlet integrating algorithm 
was used to perform numerical integration of the 
equations of motion, which follows the following 
relation: 
 
 
1 1 1
v(t) v t t v t t
2 2 2
    
= + δ + − δ    
       (1)
 
 
 The equilibration phase was validated by ensuring 
that the total energy reached a stable average value for 
all the structures. Analyzing the global energetic 
properties, such as temperature, total energy and total 
potential energy as a function of simulation time is 
important to validate the simulation protocol. The 
structures were also visually inspected for any unusual 
differences in secondary structure compositions 
between the initial and final structures. This is to 
guarantee that none of the pre-production steps have 
disturbed the original structural integrity of the 
proteins prior to submitting the structures for 
production.  
 
Table 1: Parameters employed in equilibration step 
Parameter name Parameter value 
Steps 50000 
Time step (ps) 0.0005 
Target temperature (K) 300 
Adjust velocity frequency  50 
Save results frequency 100 
Constant pressure  False 
Implicit solvent model Vacuum and distance-dependent 
 dielectrics 
Dielectric constant 1 
Non bond list radius (Å) 14  
Non bond higher cut off distance (Å) 12  
Non bond lower cut off distance (Å) 10  
Electrostatics Spherical cut off 
Dynamics integrator Leapfrog verlet 
Production run:  The equilibrated system was taken as 
the starting structure for the long term molecular 
dynamics simulation, called production. In this final 
step CHARMM takes the equilibrated structure as its 
starting point. In this study, the total simulation time of 
2 ns was achieved in four cycles of 0.5 ns. This method 
ensured that the ensemble structures were of a 
reasonable size, thus enabling efficient analysis. The 
production runs were carried out on a computer 
workstation with Intel-Xeon Dual-Quad processors.  
 The production results were saved for every 500th 
step, which corresponds to every 0.5 ps. The time step 
used  for  integrating the equations of motions was 
0.001 ps. Too small a time step value covers only a 
limited proportion of the phase space and too large a 
time step may cause instabilities in the integrating 
algorithm due to high energy overlaps between atoms. 
The canonical production ensemble was used for the 
production simulation, whereby the number of atoms, 
volume and temperature is constant, better known as 
the NVT ensemble. It is better suited for this project 
as it controls the temperature during the simulation, by 
maintaining the temperature according to the 
Berendsen et al. (1984) weak coupling method.  
 
RESULTS AND DISCUSSION 
 
Backbone flexibility of GUS:  The Root Mean Square 
Deviation (RMSD) from the initial structure of the 
Human GUS enzyme was calculated for the entire 
simulation trajectory in vacuum and implicit solvent at 
300 K. In the analysis of stability of backbone atoms of 
GUS, we find that the structure in vacuum exhibited 
fewer fluctuations and the extent of fluctuations is 
smaller  compared  to implicit solvent environment 
(Fig. 1).  The larger fluctuations observed in implicit 
solvent can be attributed to the response of the protein 
backbone with the solvent environment. 
 
Secondary structures:  The stability of helical residues 
of GUS was monitored in the trajectory (Fig. 2). We 
can find that the helical regions showed less deviation 
from the initial structure in vacuum compared to 
implicit environment. The RMSD of helical residues of 
GUS in implicit solvent showed a fluctuating trend and 
reached a value of 2.3Å at the end of production, 
whereas in vacuum it was only 1.4Å.  This trend is very 
similar to the behavior of the backbone fluctuations 
observed in the previous section.  
 The simulation snapshots of human GUS in 
vacuum (Fig. 3) and implicit solvent (Fig. 4), reveal 
that the overall domain structure of GUS remains the 
same in both the environments, even though increased 
flexibility  as  inferred  from the backbone RMSD 
and  radius  of  gyration  plots  is  observed  here also. 
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Fig. 1: RMSD of GUS backbone in vacuum and implicit 
solvent 
 
 
 
Fig. 2: RMSD of helical residues of GUS in vacuum 
and implicit solvent 
 
The increased response to the solvent environment does 
not lead to any increase in the deviation from the 
regular secondary structural features.  On the contrary, 
solvent environment has more tendencies to retain the 
secondary features compared to vacuum. 
 
 
 
 
 
 
Fig. 3: Simulations of human GUS at 300 K in vacuum 
(a) 0 ns (b) 0.5 ns (c) 1 ns (d) 1.5 ns (e) 2 ns 
 
 There were more fluctuations in the individual 
helices in GUS in implicit solvent and changes were 
also observed in the beta sheet region which became 
shorter with time. From the simulation snapshots of 
human GUS in implicit solvent (Fig. 4), it can be seen 
that the structure remained relatively stable, with 
changes occurring only in turn and coil regions. At 
0.5ns there is an introduction of helical turn and beta-
sheets (shown in the box). The helical region 
disappears at 1ns and reappears in the last two frames. 
Similar behavior is noticed in vacuum also (Fig. 3). 
However, the trend is not smooth and the turn to beta 
sheet and then to turn behavior is not observed in 
vacuum.  
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Fig. 4: Simulations of human GUS at 300 K in implicit 
solvent: (a) 0 ns (b) 0.5 ns (c) 1 ns (d) 1.5 ns (e) 
2 ns 
 
 
 
Fig. 5: Radius of gyration of GUS in vacuum and 
implicit solvent 
Structural compactness: Radius of gyration was 
calculated for all the trajectories to monitor the 
structural compactness of the protein structure 
throughout the trajectory. The radius of gyration is 
often used to describe the compactness of a protein, as 
well as the folding process from the denatured state to 
the native state (Hong and Lei, 2009). It is defined as 
the root mean square distance of each atom to the 
centroid of the molecules. 
 Since globular proteins are not spherical objects, 
the radius of gyration, RG, is the atomic weight-based 
root mean square distance of all atoms from the 
common centre of gravity, XCG, YCG, ZCG, where XCG is: 
 
n n
CG j j j CG CGj 1 j 1X m X / m etc, for Y  and Z= == ∑ ∑  (2) 
 
 In Eq. 2, mj is the atomic weight of atom j with 
coordinates Xj, Yj and Zj. and RG is given as: 
 
2 1/2
G GR (R )=  (3) 
 
where, 2GR  is: 
 
n n2
G j j jj 1 j 1R m r / m= == ∑ ∑  (4)
 
 
 In the equation above, rj is the distance of the atom 
j from the centre of mass of the protein molecule.  
 As the duration of the simulation (2 ns) is not 
sufficient to reveal any protein unfolding, no inference 
on this regard can made here.  However from Fig. 5, it 
can be inferred that in spite of the increased fluctuations 
under solvent environment, the radius of gyration 
values are smaller under solvent environment implying 
that the overall structure remains more compact in 
solvent compared to the vacuum. 
 
CONCLUSION 
 
 Enzymes, being complex biomolecules have 
various contacts and their collective motion becomes 
even more complex. The solvent environment greatly 
influences the structure and dynamics of the enzyme 
and different environments lend different 
characteristics to the system under simulation. These 
differences are evident from the comparison of 
backbone stability, helical stability and the structural 
compactness with respect to simulation time in GUS 
enzyme. Molecular dynamics simulations using 
implicit solvent models provide a convenient option to 
analyze these effects.  
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